GeneNews Management Update

TORONTO, Jan. 10 /PRNewswire-FirstCall/ - GeneNews Limited , formerly ChondroGene Limited, announced today that Colin T. West, CA, has been appointed Chief Financial Officer for an interim period, replacing Colin Martin, who left the Company effective December 31, 2006. The Company has commenced an executive search and expects to engage a permanent CFO within the next three to six months.

"I want to thank Mr. Martin for his contribution and wish him well in his future endeavours," stated Dr. K. Wayne Marshall, President and CEO of GeneNews. "Mr. West's extensive financial and management experience will be important for us in this interim period as we work to build more robust accounting and management systems to support our commercialization efforts."

Mr. West's most recent executive role was CEO/President of Richtree Market Restaurants Inc., having initially joined Richtree as CFO. He has also been a member of the board of directors of a number of public and private companies with prior experience as a senior partner in a major accounting firm. Mr. West is presently a member of the Institute of Chartered Accountants of Ontario and is a principal with Atticus Interim Management, a consulting firm which specializes in interim placements of senior executives.

About GeneNews

--------------

GeneNews (formerly ChondroGene Limited) is focussed on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a blood-based test that can detect colon cancer and pre-cancerous polyps. For more information on GeneNews, visit www.genenews.com.

GeneNews Limited

CONTACT: Dr. K. Wayne Marshall, President & CEO, (416) 650-0060 x234,wmarshall@genenews.com; Bruno Maruzzo, Corporate Development, (416)650-0060 x237, bmaruzzo@genenews.com

Back to news